AI tool found new MS lesions in written MRI reports

Credibility

Interest

Share:1 min read

Key Takeaway

An AI tool accurately found new MS lesions in written MRI reports.

What They Found

Researchers built an AI tool to read written MRI reports and identify new MS lesions. It correctly identified new lesions about 97% of the time. It processed 14,888 reports in about four hours, at a cost of $28. About 79% of reports showed no new lesions of either type the tool checked. After people started B-cell drugs, more than 97% of later monitoring scans showed no new activity.

Who Should Care and Why

The study examined MRI reports from people with MS at one health system. It focused on a tool that could make written scan results easier to use in research. The researchers also used the results to study scans after people started B-cell drugs. New activity was more likely in people living in poorer neighborhoods. The study may help researchers examine MS scan results across large sets of medical records.

Important Considerations

The study used reports from one health system, so the tool may perform differently elsewhere. The abstract gives the number of reports but not the number of people they came from. The findings do not show that neighborhood poverty caused new lesions.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News